Role of PD-L1 expression as a biomarker for GEP neuroendocrine neoplasm grading.

about

PD-L1 expression in colorectal cancer defines three subsets of tumor immune microenvironments.Chemotherapeutic Treatments Increase PD-L1 Expression in Esophageal Squamous Cell Carcinoma through EGFR/ERK Activation

P2860

Q54935837-27343D64-3DD7-4A71-A3EE-6274F02F58BC Q56761471-6E1381A4-2365-4D03-8F70-8B9214441A26

P2860

Role of PD-L1 expression as a biomarker for GEP neuroendocrine neoplasm grading.

Item

http://www.wikidata.org/entity/Q38610333

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Role of PD-L1 expression as a biomarker for GEP neuroendocrine neoplasm grading.

@en

type

Item

label

Role of PD-L1 expression as a biomarker for GEP neuroendocrine neoplasm grading.

@en

prefLabel

Role of PD-L1 expression as a biomarker for GEP neuroendocrine neoplasm grading.

@en

P1476

Role of PD-L1 expression as a biomarker for GEP neuroendocrine neoplasm grading

@en

P2093

Anna Maria Valentini

http://www.w3.org/2001/XMLSchema#string

Elisabetta Cavalcanti

http://www.w3.org/2001/XMLSchema#string

Maria Lucia Caruso

http://www.w3.org/2001/XMLSchema#string

Raffaele Armentano

http://www.w3.org/2001/XMLSchema#string

P2860

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

PD-L1 expression in human cancers and its association with clinical outcomes

Cancer immunotherapy: the beginning of the end of cancer?

PD-1/PD-L1 blockades in non-small-cell lung cancer therapy

Predictive factors of activity of anti-programmed death-1/programmed death ligand-1 drugs: immunohistochemistry analysis

Current status of immunotherapy

Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms

Gastroenteropancreatic high-grade neuroendocrine carcinoma

The blockade of immune checkpoints in cancer immunotherapy

PD-L1 and Survival in Solid Tumors: A Meta-Analysis

P304

e3004

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/CDDIS.2017.401

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marcello Chieppa

P577

2017-08-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28837143

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

P932

5596583

http://www.w3.org/2001/XMLSchema#string

Role of PD-L1 expression as a biomarker for GEP neuroendocrine neoplasm grading.

about

P2860

P2860

Role of PD-L1 expression as a biomarker for GEP neuroendocrine neoplasm grading.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932